This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pinto, A. P. Articles by Crum, C. P. Search for Related Content PubMed PubMed Citation Articles by Pinto, A. P. Articles by Crum, C. P.

(American Journal of Pathology. 1999;154:1009-1015.)
© 1999 American Society for Investigative Pathology

Short Communication

Allelic Loss in Human Papillomavirus-Positive and -Negative Vulvar Squamous Cell Carcinomas

Alvaro P. Pinto* , Ming-Chieh Lin , George L. Mutter§ , Deqin Sun§ , Luisa Lina Villa and Christopher P. Crum§

From the Department of Pathology,* Federal University of Paraná, Curitiba, Brazil; the Ludwig Institute of Cancer Research, São Paulo, Brazil; National Taiwan University Hospital, Taipei, Taiwan, and the Division of Women's and Perinatal Pathology,§ Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

Vulvar squamous cell carcinoma (VSCC) is a biologically and morphologically diverse disease, consisting of human papillomavirus (HPV)-positive and -negative tumors that differ in their morphological phenotypes and associated vulvar mucosal disorders. This study analyzed the frequencies of allelic loss (loss of heterozygosity (LOH)) in HPV-positive and -negative VSCCs to identify potential targets for the study of preinvasive diseases, to determine whether HPV status influenced patterns of LOH, and to determine whether these patterns differed from HPV-positive tumors of another genital site, cervical squamous cell carcinomas (CSCC). DNA extracted from microdissected archival sections of two index tumors, one each HPV negative and positive, was analyzed for LOH at 65 chromosomal loci. Loci scoring positive with either sample were included in an analysis of 14 additional cases that were also typed for HPV. Frequencies of LOH at loci were computed in a panel of HPV-positive and -negative VSCCs. Twenty-nine loci demonstrated LOH on the initial screen and were used to screen the remaining 14 tumors. High frequencies of LOH were identified, some of which were similar to a prior karyotypic study (3p, 5q, 8p, 10q, 15q, 18q, and 22q) and others of which had not previously been described in VSCC (1q, 2q, 8q, 10p, 11p, 11q, 17p, and 21q). With the exception of 5q and 10p, there were no significant associations between frequency of LOH and HPV status in VSCC. LOH at 3p and 11q were frequent in both VSCC and CSCC; however, allelic losses at several sites, including 5q, 8q, 17p, 21q, and 22q, were much more common in VSCC. VSCCs exhibit a broad range of allelic losses irrespective of HPV status, with high frequencies of LOH on certain chromosomal arms. This suggests that despite their differences in pathogenesis, both HPV-positive and -negative VSCCs share similarities in type and range of genetic losses during their evolution. Whether the different frequencies of LOH observed between VSCC and CSCC are real or reflect differences in stage and/or tumor size remains to be determined by further comparisons. The role of these altered genetic loci in the genesis of preinvasive vulvar mucosal lesions merits additional study.

This article has been cited by other articles:

				R. P. Insinga, K.-L. Liaw, L. G. Johnson, and M. M. Madeleine A Systematic Review of the Prevalence and Attribution of Human Papillomavirus Types among Cervical, Vaginal, and Vulvar Precancers and Cancers in the United States Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1611 - 1622. [Abstract] [Full Text] [PDF]

				W. M. Schopperle and W. C. DeWolf The TRA-1-60 and TRA-1-81 Human Pluripotent Stem Cell Markers Are Expressed on Podocalyxin in Embryonal Carcinoma Stem Cells, March 1, 2007; 25(3): 723 - 730. [Abstract] [Full Text] [PDF]

				L. A. Brooks, J. A. Tidy, B. Gusterson, L. Hiller, J. O’Nions, M. Gasco, M. C. Marin, P. J. Farrell, W. G. Kaelin Jr., and T. Crook Preferential Retention of Codon 72 Arginine p53 in Squamous Cell Carcinomas of the Vulva Occurs in Cancers Positive and Negative for Human Papillomavirus Cancer Res., December 1, 2000; 60(24): 6875 - 6877. [Abstract] [Full Text]

				G. L. Mutter, M.-C. Lin, J. T. Fitzgerald, J. B. Kum, J. P. A. Baak, J. A. Lees, L.-P. Weng, and C. Eng Altered PTEN Expression as a Diagnostic Marker for the Earliest Endometrial Precancers J Natl Cancer Inst, June 7, 2000; 92(11): 924 - 930. [Abstract] [Full Text] [PDF]

				L. C. Flowers, I. I. Wistuba, J. Scurry, C. Y. Muller, R. Ashfaq, D. S. Miller, J. D. Minna, and A. F. Gazdar Genetic Changes During the Multistage Pathogenesis of Human Papiloomavirus Positive and Negative Vulvar Carcinomas Reproductive Sciences, July 1, 1999; 6(4): 213 - 221. [Abstract] [PDF]